tiprankstipranks
Trending News
More News >
Jubilant Pharmova Limited (IN:JUBLPHARMA)
:JUBLPHARMA
India Market

Jubilant Pharmova Limited (JUBLPHARMA) Financial Statements

Compare
2 Followers

Jubilant Pharmova Limited Financial Overview

Jubilant Pharmova Limited's market cap is currently ₹169.23B. The company's EPS TTM is ₹7.85; its P/E ratio is 35.23; and it has a dividend yield of 0.46%. Jubilant Pharmova Limited is scheduled to report earnings on October 31, 2025, and the estimated EPS forecast is ₹9.60. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 72.34B₹ 67.03B₹ 62.82B₹ 61.30B₹ 60.99B
Gross Profit₹ 46.99B₹ 43.52B₹ 42.00B₹ 46.42B₹ 45.63B
Operating Income₹ 23.56B₹ 20.64B₹ 19.85B₹ 25.68B₹ 26.19B
EBITDA₹ 10.48B₹ 7.93B₹ 6.46B₹ 10.66B₹ 14.68B
Net Income₹ 8.39B₹ 771.00M₹ -610.00M₹ 4.14B₹ 8.36B
Balance Sheet
Cash & Short-Term Investments₹ 10.89B₹ 9.56B₹ 10.15B₹ 9.86B₹ 6.89B
Total Assets₹ 127.56B₹ 115.48B₹ 111.57B₹ 99.91B₹ 89.18B
Total Debt₹ 27.31B₹ 36.64B₹ 36.77B₹ 31.92B₹ 28.30B
Net Debt₹ 16.42B₹ 27.10B₹ 26.63B₹ 22.12B₹ 23.32B
Total Liabilities₹ 65.18B₹ 61.27B₹ 57.65B₹ 46.74B₹ 41.77B
Stockholders' Equity₹ 62.55B₹ 54.34B₹ 53.99B₹ 53.19B₹ 47.41B
Cash Flow
Free Cash Flow₹ -435.00M₹ 736.00M₹ -1.54B₹ 2.38B₹ 12.57B
Operating Cash Flow₹ 10.72B₹ 9.71B₹ 6.61B₹ 8.38B₹ 17.84B
Investing Cash Flow₹ 4.88B₹ -6.08B₹ -5.44B₹ -3.80B₹ -7.39B
Financing Cash Flow₹ -14.53B₹ -4.33B₹ -1.57B₹ -325.99M₹ -17.09B
Currency in INR

Jubilant Pharmova Limited Earnings and Revenue History

Jubilant Pharmova Limited Debt to Assets

Jubilant Pharmova Limited Cash Flow

Jubilant Pharmova Limited Forecast EPS vs Actual EPS